Rozlyn S. Lipsey - 25 Oct 2021 Form 3 Insider Report for MedMen Enterprises, Inc.

Footnote F1

Represents restricted stock units ("RSUs"), granted 9/9/2020 pursuant to Issuer's 2018 Stock and Incentive Plan (the "Incentive Plan"), which vest annually over four years with 37.5% vesting on 6/30/2021 and 6/30/2023, and 12.5% vesting on 6/30/2022 and 6/30/24. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.

Footnote F2

Represents RSUs granted 8/29/2021 pursuant to the Incentive Plan, which vest annually over four years with 37.5% vesting on 6/30/2022 and 6/30/2024, and 12.5% vesting on 6/30/2023 and 6/30/25. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of Shares.

Footnote F3

Employee stock options (right to buy) ("Options") granted pursuant to the Incentive Plan.

Footnote F4

Options vest over four years with 25% vesting on January 7, 2020. The balance vest equally on a monthly basis thereafter.

Footnote F5

Such Options have an exercise price of CAN$4.53, which is equivalent to US$3.42 at an exchange rate of 0.7544 as of the grant date.

Footnote F6

Such Options have an exercise price of CAN$0.22, which is equivalent to US$0.1670 at an exchange rate of 0.7591 as of the grant date.

Footnote F7

Such Options have an exercise price of CAN$0.355, which is equivalent to US$0.2814 at an exchange rate of 0.7925 as of the grant date.